Home Healthcare Pharmaceuticals Orphan Drug Market

Orphan Drug Market Size, Share & Trends Analysis Report By Drug Type (Biologicals, Non-Biologicals), By Therapy Type (Oncology, Haematology, Neurology, Infectious Diseases, Metabolic Disorders, Endocrinology, Immunology, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Orphan Drug Market, By Drug Type 2022-2034 (USD MILLION/ Units)
    1. Biologicals
    2. Non-Biologicals
  2. Orphan Drug Market, By Therapy Type 2022-2034 (USD MILLION/ Units)
    1. Oncology
    2. Haematology
    3. Neurology
    4. Infectious Diseases
    5. Metabolic Disorders
    6. Endocrinology
    7. Immunology
    8. Others
  3. Orphan Drug Market, By Distribution Channel 2022-2034 (USD MILLION/ Units)
    1. Hospital Pharmacies
    2. Retail Pharmacies
    3. Online Pharmacies
    4. Others
  4. Regional Orphan Drug Market
    1. North America
      1. North America Orphan Drug Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologicals
        2. Non-Biologicals
      2. North America Orphan Drug Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Haematology
        3. Neurology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Endocrinology
        7. Immunology
        8. Others
      3. North America Orphan Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
      4. U.S.
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      5. Canada
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
    2. Europe
      1. Europe Orphan Drug Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologicals
        2. Non-Biologicals
      2. Europe Orphan Drug Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Haematology
        3. Neurology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Endocrinology
        7. Immunology
        8. Others
      3. Europe Orphan Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
      4. U.K.
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      5. Germany
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      6. France
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      7. Spain
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      8. Italy
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      9. Russia
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      10. Nordic
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      11. Benelux
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      12. Rest of Europe
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
    3. APAC
      1. APAC Orphan Drug Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologicals
        2. Non-Biologicals
      2. APAC Orphan Drug Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Haematology
        3. Neurology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Endocrinology
        7. Immunology
        8. Others
      3. APAC Orphan Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
      4. China
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      5. Korea
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      6. Japan
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      7. India
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      8. Australia
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      9. Taiwan
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      10. South East Asia
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      11. Rest of Asia-Pacific
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
    4. Middle East and Africa
      1. Middle East and Africa Orphan Drug Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologicals
        2. Non-Biologicals
      2. Middle East and Africa Orphan Drug Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Haematology
        3. Neurology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Endocrinology
        7. Immunology
        8. Others
      3. Middle East and Africa Orphan Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
      4. UAE
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      5. Turkey
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      6. Saudi Arabia
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      7. South Africa
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      8. Egypt
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      9. Nigeria
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      10. Rest of MEA
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
    5. LATAM
      1. LATAM Orphan Drug Market By Drug Type 2022-2034 (USD MILLION/ Units)
        1. Biologicals
        2. Non-Biologicals
      2. LATAM Orphan Drug Market By Therapy Type 2022-2034 (USD MILLION/ Units)
        1. Oncology
        2. Haematology
        3. Neurology
        4. Infectious Diseases
        5. Metabolic Disorders
        6. Endocrinology
        7. Immunology
        8. Others
      3. LATAM Orphan Drug Market By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
        4. Others
      4. Brazil
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      5. Mexico
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      6. Argentina
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      7. Chile
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      8. Colombia
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
      9. Rest of LATAM
        1. Biologicals
        2. Non-Biologicals
        3. Oncology
        4. Haematology
        5. Neurology
        6. Infectious Diseases
        7. Metabolic Disorders
        8. Endocrinology
        9. Immunology
        10. Others
        11. Hospital Pharmacies
        12. Retail Pharmacies
        13. Online Pharmacies
        14. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.